Nordea Investment Management’s Aerie Pharmaceuticals AERI Stock Holding History

Nordea Investment Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-88,766	Closed	-$1.34M	–	993
2022 Q3	$1.34M	Sell	88,766 -613	-0.7%	-$7.13K	﹤0.01%	742
2022 Q2	$690K	Buy	89,379 +51,070	+133%	+$360K	﹤0.01%	860
2022 Q1	$356K	Buy	38,309 +4,751	+14%	+$36.6K	﹤0.01%	924
2021 Q4	$242K	Buy	+33,558	New	+$351K	﹤0.01%	964

Nordea Investment Management's AERI Position: Q4 2022 in Review

Nordea Investment Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 88,766 shares — an estimated $1.34M sold.

Nordea Investment Management first reported a position in AERI in Q4 2021 and held it in 4 quarters. The position peaked at $1.34M in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Nordea Investment Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Nordea Investment Management sold 88,766 Aerie Pharmaceuticals shares in Q4 2022, an estimated $1.34M.
Nordea Investment Management first reported a position in Aerie Pharmaceuticals in Q4 2021 and held it in 4 quarters.
Nordea Investment Management's Aerie Pharmaceuticals position peaked at $1.34M in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Nordea Investment Management's 13F filing for Q4 2022, filed 8 Feb 2023.